BCI Marketplace
Deep Brain Stimulation trials

Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy

RecruitingNCT05493722Phase: EARLY_PHASE1Started 2023-09-15

Summary

Deep brain stimulation (DBS) is used to treat epilepsy in cases where patients are medically refractory and are not candidates for surgical resection. This therapy has been shown to be effective in seizure reduction, yet very few patients achieve the ultimate goal of seizure freedom. Implantable neural stimulators (INSs) have many parameters that may be adjusted, and could be tuned to achieve very patient specific therapies. This study will develop a platform for stimulation setting optimization

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: * medically refractory epilepsy * already have a deep brain stimulator in place Exclusion Criteria: * severe dementia at investigator discretion

Locations

University of Minnesota
Minneapolis, Minnesota, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →